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(StopAdvisor) in people with low and high socioeconomic 
status: a randomised controlled trial
Jamie Brown, Susan Michie, Adam WA Geraghty, Lucy Yardley, Benjamin Gardner, Lion ShahabJohn A Stapleton[A;correct?], Robert West
Summary
Background Internet-based interventions for smoking cessation could help millions of people stop smoking at very 
low unit costs; however, evidence is scarce and such interventions might be less effective for smokers with low 
socioeconomic status [A:why?]. We aimed to assess a new interactive internet-based intervention (StopAdvisor) for 
smoking cessation in people with low and high socioeconomic status.
Methods We did this randomised controlled trial between Dec 6, 2011, and Oct 11, 2013, [A: correct?] at XX [A: please 
provide number of centres] centres in the UK. Participants aged 18 years and older who smoked every day were 
randomly assigned (1:1) to receive treatment with StopAdvisor or an information-only website. Randomisation was 
automated with an unseen random number function embedded in the website to establish which treatment was 
revealed after the online baseline assessment [A: was this stratified for SES?]. Participants, and researchers who 
obtained data and did laboratory analyses, were masked to treatment allocation. The primary outcome was 6 month 
sustained, biochemically verified abstinence [A:in the overall group and in the pre-specified SES subsamples?]. [A: 
data for secondary endpoints have been removed because we avoid their inclusion in the summary, but all details 
remain in the text and tables]. Analysis was by intention to treat. The study is registered as an International Standard 
Randomised Controlled Trial, number ISRCTN99820519.
Findings We randomly assigned 4613 participants to the StopAdvisor group (n=2321) or the control group (n=2292); 
2142 participants were of lower socioeconomic status and 2471 participants were of higher status. The overall rate of 
smoking cessation was similar between participants in the StopAdvisor and control groups for the primary outcome 
(n=237 [10%] vs n=220 [10%]; relative risk [RR] 1·06, 95% CI 0·89–1·27; p=0·49). However, the intervention effect 
differed across socioeconomic status subsamples (RR 1·44, 95% CI 0·99–2·09; p=0·0562). StopAdvisor helped 
participants with lower socioeconomic status stop smoking compared with the information-only website (90 [8%] of 
1088 participants vs 64 [6%] of 1054 participants; RR 1·36, 95% CI 1·00–1·86; p=0·0499, but did not improve cessation 
rates in those with higher socioeconomic status (147 [12%] of 1233 participants vs 156 [13%] of 12 388 participants; 
0·95, 0·77–1·17; p=0·61).
Interpretation StopAdvisor was more effective than an information-only website in smokers of lower, but not higher, 
socioeconomic status. [A: please add a sentence explaining the clinical implications of your findings. What should 
clinicians do now?]
Funding National Prevention Research Initiative.
Copyright © Brown et al. Open Access article distributed under the terms of CC BY. 
Introduction
Tobacco smoking is estimated to cause more than 
6 million deaths worldwide every year,1 and is a major 
contributor to health inequalities.2 Almost all the 
mortality and morbidity associated with smoking could 
be avoided by smokers quitting before age 30 years;3 
however, in most developed countries, less than a quarter 
of smokers quit before this age, despite most wanting 
and trying to stop.4 Face-to-face support combined with 
drugs is the most effective intervention for cessation, 
whereas unaided quitting is one of the least effective 
methods.5,6 Despite this finding, even in the UK, where 
treatment is widely accessible at little or no cost, most 
smokers do not use face-to-face support and almost half 
attempt to stop unaided.7 Improved ways to help and 
engage smokers who are trying to stop are urgently 
needed, particularly for those from low socioeconomic 
status groups who want to stop as much as other 
smokers, but find it more difficult [A:why?], further 
widening social inequalities. 8
Internet support is a low-cost option for treatment of 
smoking cessation, which could reach millions of 
smokers who would otherwise attempt to quit unaided. 
Roughly 70% of smokers in the UK have regular internet 
access and almost half are interested in use of online 
support during a future quit attempt. 9 The internet could 
appeal to smokers who are reluctant to engage with face-
to-face support by offering increased convenience, 
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confidentiality, and reduced stigma, while presenting an 
alternative for those struggling to access face-to-face 
support because of mobility or geographical barriers. The 
benefits compared with other low-cost and convenient 
alternatives, such as written materials, include 
opportunities for interactivity and tailoring. Despite the 
potential of internet-based interventions, previous 
research into their effectiveness has produced mixed 
results and is limited by a scarcity of biochemically 
verified long-term outcomes.10 Furthermore, such 
interventions might be less effective for smokers with 
low socioeconomic status than for those with high status 
[A:why?].11 Which components account for the differences 
in effectiveness [A: between SES groups?] is unclear, 
because internet interventions have often been presented 
as so-called black boxes, with restricted description of 
their content. 10 To establish the crucial components of an 
effective intervention, researchers should report 
transparently the content of new smoking cessation 
websites.12
StopAdvisor is a new interactive smoking cessation 
website and, to promote transparency, details of both 
the content and development of the website have been 
published,13 and the website built with the open-source 
platform LifeGuide. The development of StopAdvisor 
was informed by addiction theory, previous research, 
and user-testing with smokers of low socioeconomic 
status [A:only low SES? Not Higher SES?]. In a pilot 
study, StopAdvisor showed promising short-term 
effectiveness and usability,14 we therefore aimed to 
assess the long-term effectiveness of the intervention in 
this trial.
Health inequality is a priority and to assess what affect 
new interventions have on different social groups is 
important.15 Most assessments of behavioural 
interventions have not been adequately powered to 
detect effects in low-income groups,16 and no previous 
trial of internet support for smoking cessation has 
focused on the effect within different socioeconomic 
status groups. This absence of research exists despite 
concerns that online support might be more effective 
for smokers with high socioeconomic status on the 
basis of their apparent greater literacy to engage with 
support websites compared with smokers with low 
status. 11 To address this issue, the pilot study of 
StopAdvisor reported analyses showing that the 
intervention was similarly effective and acceptable to 
users across the range of socioeconomic status groups.14 
The implication was that typical inequalities in online 
literacy might have been successfully mitigated by user 
testing done in a panel of smokers with low 
socioeconomic status during the development of 
StopAdvisor.13 However, the robustness of this finding 
needed assessment within an adequately powered trial. 
As such, we did this study to examine the effectiveness 
of StopAdvisor in smokers of low and high 
socioeconomic status.
Methods
Study design and participants
We did this randomised controlled between Dec 6, 2011, 
and Oct 11, 2013, [A: correct?] at XX sites in the UK [A: at 
how many study sites in the UK?]. We enrolled 
participants aged 18 years and older who smoked every 
day and who were willing to make a serious quit attempt, 
use a stop-smoking website that sends email reminders, 
be followed up at 7 months, and be contacted by email 
and telephone. Participants were recruited mainly via a 
notice on the English Department of Health website 
called SmokeFree. The notice invited smokers to take 
part in a study comparing methods of online support, 
and included a link to the study website. Individuals 
interested in participating after reading the study 
information and eligibility criteria were asked for 
informed consent and to complete a baseline 
questionnaire. The study was designed with sufficient 
power to assess effectiveness [A: we use efficacy to refer 
to how well a drug works in a trial setting] within each 
socioeconomic status subsample separately in the event 
of heterogeneity; as such, recruitment continued until 
the required sample size had been achieved for 
subsamples of both higher and lower socioeconomic 
status. [A: edited to avoid repetition] The study was 
approved by the ethics committee of University College 
London (reference 2808/001). The protocol17 was 
approved by a trial steering committee.
Randomisation and masking
Participants who completed the baseline questionnaire 
were randomly assigned (1:1) to StopAdvisor or an 
information-only control website—a one-page static 
website giving brief standard advice,13 based on a widely 
used manual for smoking cessation for practitioners.19
Randomisation was at the individual level with no 
restriction (ie, no blocking) and was completely 
automated with no experimenter involvement by use of 
an unseen random number function embedded in the 
website code to identify which treatment website was 
revealed after participants clicked the submit button at 
the end of the questionnaire [A:was it stratified for SES 
group to ensure equal numbers for each intervention?]. 
After treatment allocation, the email address of each 
participant was secured to that website to prevent 
contamination. Participants, and researchers who 
obtained data and did laboratory analyses, were masked 
to treatment allocation. We did no formal assessment of 
the extent to which masking was successful.
Procedures
Development and content of the StopAdvisor website 
has been described in detail elsewhere.13 Briefly, the 
development was informed by 19 theoretical 
propositions identified from the PRIME theory of 
motivation and addiction,18 33 evidence-based or theory-
based behaviour change techniques, 26 web-design 
For more about StopAdvisor see 
http://www.lifeguideonline.org/
player/play/
stopadvisordemonstration
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principles, and nine principles from user testing with 
smokers of low socioeconomic status. The theme of the 
website was based on the success of the UK’s National 
Health Service (NHS) Stop Smoking services and was 
aimed to simulate an expert stop smoking advisor who 
was both a source of useful information and a guide to 
help the smoker through the process of stopping with a 
structured quit plan. Tailored support was offered for up 
to 1 month before and after quitting. The website was 
presented on a standard template and used a hybrid 
navigational architecture combining choice of content 
from menus with tunnelled exposure to key messages. 
Before their quit date, participants had access to an 
interactive menu, which included a screencast 
explaining how to use the website, and up to five 
tunnelled dialogue sessions tailored according to their 
quit date, their intended use of smoking cessation 
[A ;ok?] medicines, their success in obtaining and use of 
medicines, and reasons for quitting. These sessions 
presented behaviour-change techniques that focused on 
helping with goal setting and action planning around a 
quit date, emphasising the importance of abrupt 
cessation, acquiring appropriate medicines and how 
best to use them , making necessary changes in routines 
to minimise urges to smoke after the target quit date, 
developing specific coping strategies for anticipated 
difficulties in quitting [A;ok?], and having clear 
expectations about the natures of those difficulties. In 
each case, delivery of a technique was designed to make 
use of the interactive nature of the intervention—eg, an 
interactive calendar to set quit dates and email 
reminders. After their quit date, participants had access 
to a new interactive menu and up to 13 tunnelled 
sessions tailored on self-reported abstinence, urges to 
smoke, self-effectiveness, medicine use, and anticipated 
frequency of stressful or social events. The responses 
variously aimed to boost motivation and self-
effectiveness and strengthen the identity of ex-smokers, 
and provided specific advice and behaviour-change 
techniques about how to address potential difficulties 
and plan for the future to minimise their occurrence. 
The post-quit menu included frequently asked 
questions, a ”your progress” section, audio and video, 
and a link to the StopAdvisor Facebook page.13
Procedures
Follow-up was 7 months after enrolment to allow an 
outcome of at least 6 months abstinence; both websites 
advised quit dates within 1 month of enrolment. Follow-
up data were obtained via an online questionnaire 
emailed to participants. Non-responders were sent 
reminders using both email and telephone contact 
details (at least one and up to three telephone numbers 
[daytime, evening, and mobile]), with invitations and 
contacts structured according to evidence-based methods 
for maximisation of response rates. 20 For example, all 
invitations were personalised, cited non-monetary 
incentives for responding (eg, how the answer was 
important and would inform decisions about whether to 
make the websites more widely available), and referred to 
university sponsorship of the trial, while attempts at 
direct contact were preceded by a pre-contact, which 
informed the participant they would soon be contacted. 
Participants who reported meeting either 6 month 
sustained abstinence or point-prevalence criteria (defined 
as a self-report of not smoking in the previous 7 days at 
follow up) at 7-month follow up were asked to use a 
cotton dental roll to provide a saliva sample and post it 
back to a laboratory for analysis. To improve response 
rates, these participants received a £20 gift voucher, 
irrespective of whether or not they returned the sample 
[A: was the voucher only sent to those who quit/were to 
return a sample or all patients who completed the 
questionnaire irrespective of their quit status?]. 20
On enrolment individuals were automatically classified 
into one of two socioeconomic status subsamples as 
established by their responses to the baseline 
questionnaire: (1) lower socioeconomic status, 
comprising individuals who have never worked, were 
long-term unemployed, or were from routine and 
manual occupations according to the National Statistics 
Socio-Economic Classification (NS-SEC) self-coded 
method,21 and (2) higher socioeconomic status, 
comprising individuals who were classified into all other 
occupational groups with the NS-SEC self-coded method.
Outcomes
The primary outcome was Russell Standard 6 month 
sustained abstinence (RS6), defined as self-reported non-
smoking of more than five cigarettes in the previous 
6 months and not smoking in the previous week, verified 
by a saliva cotinine concentration of less than 15 ng/mL22 
or, for participants reporting use of nicotine replacement 
treatment (including electronic cigarettes) and with a 
saliva cotinine concentration of more than 14 ng/ml, a 
saliva anabasine concentration of less than 1 ng/mL.23 
This definition classified participants who self-reported 
not smoking but did not meet the biochemical verification 
criterion as continuing smokers.
Secondary outcomes were point prevalence 
abstinence,20 verified by saliva cotinine or anabasine; 
andquantitative indices of website interaction (logins, 
page views, and time spent on website).We also assessed 
self-reported abstinence at months 2 and after enrolment, 
self-report of a serious quit attempt at the 7-month follow 
up, and satisfaction ratings of the website at months 2 and 
7 after enrolment. Due to low response rates for these 
outcomes they were omitted from the main analyses 
before unblinding the data (appendix).
Measures recorded for outcome assessment at follow 
up were self-reported smoking behaviour in the previous 
6 months and specifically the previous week, and a saliva 
sample to verify those reporting abstinence in the 
previous week.
See Online for appendix
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Statistical analysis
The sample size was established with α and β (1-power) 
set at 5% for a projected 3% intervention difference (ie 
8% vs 5%) in the whole sample, whilst ensuring at least 
80% power to detect this difference in either 
socioeconomic status subsample in the event of 
heterogeneity. Although the anticipated effect size is 
smaller than usually observed with face-to-face 
behavioural support, it is clinically meaningful and 
potentially cost-effective.24 Hence, a minimum total 
sample size of 4260 with at least 2130 in each subsample 
was required.
We used log-binomial regression to analyse the 
dichotomous primary and secondary outcomes, and 
calculated the associated relative risk and 95% CIs. The 
model allowed both the initial assessment of 
homogeneity of effect across subsamples by inclusion 
of an intervention by socioeconomic status interaction 
term and adjustment in sensitivity analyses for any 
chance imbalances in baseline characteristics between 
intervention and subsamples. The interaction term 
provided an assessment of the homogeneity of effect 
because it represented the ratio of the risk ratios (RRs) 
for the intervention effect in the subsample of 
participants with lower socioeconomic status and the 
intervention effect in those with higher status. So far as 
the true intervention effect was the same in both 
subsamples, the RRs would be identical (except for 
sampling error) and their ratio would be about 1—ie, 
no interaction. Alternatively, an interaction in the 
initial analysis would show heterogeneous intervention 
effects across socioeconomic status subsamples, which 
should therefore be assessed separately within each 
subsample. We anticipated the possibility of 
heterogeneity and thus specified the threshold for 
absence of homogeneity of effect was specified at a p 
value of less than 0·10.25,26 The protocol specified 
logistic regression and associated odds ratios (ORs) as 
the measure of effect, but we used relative risk to 
improve understanding. On the basis of the intention-
to-treat principle, individuals who did not respond to 
endpoint follow-up attempts were retained in the 
analyses and classified as continuing smokers 
according to the RS6 criteria.22 To provide per-protocol 
analyses, we also calculated ORs, percentage-point 
differences. and 95% CIs. As post-hoc sensitivity 
analyses, we re-examined the models: with exclusion of 
participants in full-time education from the 
Figure 1: Trial profile
Eight participants violated the protocol by using an alternative email address to view the other website to which they were allocated (higher SES: StopAdvisor n=1, control n=4; lower SES: StopAdvisor 
n=2, control n=1). Per protocol, these participants were not excluded from the analysis and classified by the original treatment to which they were allocated. Only one of these participants met either 
the primary or secondary outcome abstinence criteria: the participant was from the higher SES subgroup and was allocated to the control website and viewed StopAdvisor. SES=socioeconomic status
7785 participants read study information 
2321 assigned to StopAdvisor
1088 lower SES 
314 lost to follow-up
68 previously reported
smoking
246 assumed to have
returned to smoking 
364 lost to follow-up
51 previously reported
smoking
313 assumed to have
returned to smoking 
724 contacted at 7-month follow-up 
1088 included in primary analysis 1233 included in primary analysis 1054 included in primary analysis 1238 included in primary analysis 
919 contacted at 7-month follow-up 710 contacted at 7-month follow-up 960 contacted at 7-month follow-up 
344 lost to follow-up
69 previously reported
smoking
275 assumed to have
returned to smoking 
278 lost to follow-up
70 previously reported
smoking
208 assumed to have
returned to smoking 
1233 higher SES 1238 higher SES 
2292 assigned to StopAdvisor
3172 excluded
1298 declined to give consent
1419 did not complete baselines
455 ineligible
361 not from the UK
75 not daily smokers
19 duplicate sign ups
1054 lower SES 
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classification of those in the subsample with lower 
socioeconomic status to assess the effect on results of 
individuals who might have been inappropriately 
classified ; with reclassification of individuals with 
lower socioeconomic status as those who did not have 
post-16 education to assess whether results extended 
across an alternative operationalisation of socio-
economic status; and with self-reported smoking 
cessation at the 7 month endpoint to show the effect of 
biochemical verification. We compared website usage 
with t tests without the assumption of equality of 
variance. We did analyses with SPSS (version 22.0.0.0).
The study is registered as an International Standard 
Randomised Controlled Trial, number ISRCTN99820519.
Role of funding source [A: edited based on our standard 
wording for when funders have had no role]
The sponsor of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. JB, JAS, and RW had full access to 
all the data in the study and JB had final responsibility for 
the decision to submit for publication.
Results 
[A: our style is to not include subheadings in this 
section] [A: when data are shown in tables or 
figures, we avoid repeating them in the text]
Figure 1 shows the trial profile.27 We randomly assigned 
4613 participants to the StopAdvisor group (n=2321) or 
the control group (n=2292); 2142 participants were of 
lower socioeconomic status and 2471 participants were of 
higher status (figure 1). 1300 (28%) participants were lost 
to follow-up (figure 1). However, of these, 258 (20%) 
individuals reported usual smoking at an earlier time in 
the previous 6 months[A: correct?], which would have 
classified them as smokers by our sustained abstinence 
(RS6) primary outcome, meaning that the effective 
follow-up rate for the primary outcome was 77% 
(1300 − 258=1042, 4613 − 1042=3571, 3571/4613). This rate 
was not dissimilar between intervention groups, or 
between patients in different socioeconomic subsamples 
(figure 1). The remaining 1042 (23%) participants were 
assumed to have continued smoking according to RS6 
criteria. Baseline characteristics of participants assumed 
to be smoking did not differ between intervention groups, 
Lower SES (N=2142)* Higher SES (N=2471) Total (N=4613)
StopAdvisor 
(n=1088)
Control 
(n=1054)
StopAdvisor 
(n=1233)
Control 
(n=1238)
StopAdvisor 
(n=2321)
Control 
(n=2292)
Female 658 (61%) 632 (60%) 804 (65%) 796 (64%) 1462 (63%) 1428 (62%)
Age (years) 39·8 (14·8) 39·4 (14·3) 39·2 (11·3) 38·3 (10·9) 39·5 (13·0) 38·8 (12·5)
Married 504 (46%) 490 (47%) 643 (52%)) 641 (52%) 1147 (49%) 1131 (49%)
Having children 704 (65%) 690 (66%) 678 (55%) 656 (53%) 1382 (60%) 1346 (59%)
White ethnic origin 1029 (95%) 970 (92%) 1152 (93%) 1134 (92%) 2181 (94%) 2104 (92%)
Presently in full-time education 121 (11%) 116 (11%) 71 (6%) 71 (6%) 192 (8%) 187 (8%)
No post-16 years old educational qualification 548 (50%) 525 (50%) 321 (26%) 293 (24%) 869 (37%) 818 (36%)
Cigarettes smoked per day 20·5 (9·4) 20·3 (9·4) 17·1 (8·1) 16·9 (8·3) 18·7 (8·9) 18·5 (9·0)
Age of smoking initiation (years)† 16·2 (5·3) 16·2 (4·3) 17·2 (4·9) 17·1 (4·2) 16·7 (5·1) 16·7 (4·2)
Never previously used support in a quit attempt 431 (40%) 434 (41%) 450 (37%) 509 (41%) 881 (38%) 943 (41%)
Never previously used behavioural support in a 
quit attempt
616 (57%) 637 (60%) 721 (59%) 798 (65%) 1337 (58%) 1435 (63%)
Made quit attempt in the previous year 394 (36%) 353 (34%) 457 (37%) 441 (36%) 851 (37%) 794 (35%)
Confidence in stopping score (1–7) 4·8 (1·7) 4·7 (1·7) 4·6 (1·6) 4·7 (1·6) 4·7 (1·7) 4·7 (1·6)
Never stopped for more than 1 week 459 (42%) 433 (41%) 348 (28%) 388 (31%) 807 (35%) 821 (36%)
Usually smokes within 5 min of waking 465 (43%) 400 (38%) 324 (26%) 298 (24%) 789 (34%) 698 (31%)
HSI score (0–6) 3·5 (1·4) 3·4 (1·4) 2·8 (1·5) 2·7 (1·5) 3·1 (1·5) 3·0 (1·5)
FTND score (0–10) 5·6 (2·3) 5·5 (2·3) 4·6 (2·5) 4·5 (2·4) 5·1 (2·4) 5·0 (2·4)
Time with smoking urges score (0–5) 3·1 (1·1) 3·0 (1·1) 2·7 (1·0) 2·7 (1·0) 2·9 (1·1) 2·9 (1·0)
Strength of smoking urges score (0–5) 3·3 (1·0) 3·2 (1·0) 3·0 (1·0) 3·0 (1·0) 3·1 (1·0) 3·1 (1·0)
MPSS-mood subscale (0–4)‡ 2·6 (0·9) 2·5 (0·9) 2·3 (0·8) 2·3 (0·8) 2·4 (0·9) 2·4 (0·9)
Time to complete online recruitment (min) 11·3 (6·8) 11·3 (6·0) 10·3 (5·9) 10·1 (6·1) 10·8 (6·4) 10·7 (6·1)
Pages viewed to complete online recruitment 19·2 (2·5) 19·1 (1·9) 19·7 (2·5) 19·5 (1·5) 19·5 (2·5) 19·3 (1·7)
Data are n (%) or mean (SD), unless otherwise indicated. SES=socioeconomic status. HIS=heaviness of smoking index.28 FTND= Fagerström test for nicotine dependence.28 
MPSS=mood and physical symptoms scale. *Lower SES individuals were those who had never worked, were long-term unemployed, or were from routine and manual 
occupations according to the National Statistics Socio-Economic Classification self-coded method.21 †Data for age of smoking initiation were missing for seven participants 
(higher SES: n=1StopAdvisor, n=1 control; lower SES: n=3 StopAdvisor, n=2 control). ‡The MPSS-mood subscale is the mean of responses to five separate states: depressed, 
irritable, restless, hungry, and poor concentration.
Table 1: Baseline characteristics [A: letters indicating significance have been deleted because any differences between groups at this stage should be due 
to chance (if randomised properly)]
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or between participants in different socioeconomic status 
subsamples (data not shown).
In the recruited sample, daily cigarettes smoked and 
measures of tobacco dependence28 were high and a third 
of participants had not stopped for more than 1 week 
since becoming a regular smoker (table 1). About 60% of 
participants had never previously used any behavioural 
support during a quit attempt, while about 40% had 
never previously used any type of smoking cessation 
treatment (table 1). Baseline characterises were mostly 
similar in the two intervention groups overall and among 
participants with different socioeconomic status; 
however, individuals in the control group were more 
likely than those in the StopAdvisor group to have never 
previously used behavioural support, a difference that 
was also evident in the higher, but not the lower, 
socioeconomic status subsample (table 1). Both 
intervention groups, irrespective of socioeconomic 
status, showed a similar level of engagement with the 
trial recruitment website, spending roughly 11 min to 
view and interact with a mean of 19 pages (table 1).
The overall rate of smoking cessation was similar 
between participants in the StopAdvisor and control 
groups for both the primary (n=237 [10%] vs n=220 [10%]; 
relative risk [RR] 1·06, 95% CI 0·89–1·27; p=0·49) and the 
secondary (n=358 [15%] vs n=332 [15%]; 1·06, 0·93–1·22; 
p=0·37) outcomes. However, analysis of the interaction 
between intervention and socioeconomic status showed 
clear evidence of non-ignorable heterogeneity of 
intervention effect by both primary (RR 1·44, 95% CI 
0·99–2·09; p=0·0562) and secondary (RR 1·37, 1·02–1·84; 
p=0·0360) cessation measures. This finding was evident 
before and after adjustment for all other baseline 
characteristics (data not shown [A: ok?]). Consequently, 
the analysis of outcome was done separately within each 
of the two socioeconomic status subsamples.
In the subsample of patients with lower socioeconomic 
status, a benefit of StopAdvisor was evident for both 
primary and secondary measures compared with the 
information-only website, whereas in those with higher 
socioeconomic status, no evidence of a difference was 
shown (table 2). Adjustment for all baseline 
characteristics had a negligible effect on these 
comparisons (table 2). In a post-hoc sensitivity analysis, 
we re-examined the effect of StopAdvisor on 
biochemically verified smoking cessation in participants 
with lower socioeconomic status, after exclusion of those 
in full-time education from the classification (n=237). 
The benefit of StopAdvisor compared with the 
information-only website remained in both unadjusted 
(primary outcome 87 [9%] of 967 vs 60 [6%] of 938 
participants; RR 1·41, 95% CI 1·03–1·93; p=0·0346; 
secondary outcome 130 [13%] vs 88 [9%] participants; 
1·43, 1·11–1·85; p=0·0057) and adjusted (primary 
outcome 1·48, 1·07–2·04; p=0·0170; secondary outcome 
1·52, 1·18–1·97; p=0·0013) models. In a second 
sensitivity analysis, we re-examined the models with 
lower socioeconomic status participants reclassified as 
those who did not have post-16 education. In this smaller 
subsample (n=1687), the results were consistent with the 
primary analyses for StopAdvisor versus information 
only, but were non-significant in both the unadjusted 
(primary outcome 80 [9%] of 869 vs 60 [7%] of 
818 participants; RR 1·26, 95% CI 0·91–1·73; p=0·17; 
secondary outcome 111 [13%] vs 86 [11%] participants; 
1·21, 0·93–1·58; p=0·15) and adjusted (primary outcome 
1·27, 0·92–1·75; p=0·15; secondary outcome 1·21, 
0·92–1·58; p=0·17) models. In a final post-hoc sensitivity 
analysis, we re-examined the effect of StopAdvisor with 
self-reported rather than biochemically verified measures 
of smoking cessation at the 7 month endpoint. On the 
basis of similar rates of failing the biochemical 
StopAdvisor Control Relative risk (95% CI)* Odds ratio (95% CI)† Percentage-point 
difference (95% CI)
p value‡
Primary outcome (abstinence for 6 months)
Higher SES 147/1233 (12%) 156/1238 (13%) 0·95 (0·77 to 1·17) 0·94 (0·74 to 1·19) –0·68 (–3·27 to 1·91) 0·61
Adjusted [A1] .. .. 0·97 (0·78 to 1·19)§ 0·95 (0·75 to 1·22)§ .. 0·75
Lower SES 90/1088 (8%) 64/1054 (6%) 1·36 (1·00 to 1·86) 1·39 (1·00 to 1·94) 2·20 (0·02 to 4·38) 0·0499
Adjusted [A1] .. .. 1·43 (1·05 to 1·96)§ 1·46 (1·04 to 2·05)§ .. 0·025
Secondary outcome (point prevalence at 6 months)
Higher SES 222/1233 (18%) 232/1238 (19%) 0·96 (0·81 to 1·13) 0·95 (0·78 to 1·17) –0·74 (–3·79 to 2·32) 0·64
Adjusted [A1] .. .. 0·96 (0·82 to 1·14)§ 0·95 (0·77 to 1·17)§ .. 0·66
Lower SES 136/1088 (13%) 100/1054 (10%) 1·32 (1·03 to 1·68) 1·36 (1·04 to 1·79) 3·01 (0·37 to 5·66) 0·027
Adjusted [A1] .. .. 1·39 (1·09 to 1·78)§ 1·41 (1·07 to 1·88)§ .. 0·0081
Data are n/N (%), unless otherwise indicated. SES=socioeconomic status. The rate for reporting not smoking but failing to provide biochemical verification was 5% 
(207/4613) for the primary outcome and 9% (392/4613) for the secondary outcome; these rates were similar between the intervention groups in each SES subsample. 
Participants lost to follow-up were counted as treatment failures. *The primary analyses were all unadjusted. †Odds ratios rather than relative risks were specified as the 
measure of effect in the protocol. Relative risks were also calculated to improve understanding. ‡In the case of the adjusted analyses, p values relate to the log-binomial 
models used to calculate the relative risk. §Adjusted results are presented as a sensitivity analysis. The adjusted models include all characteristics presented in table 1. [A1: is 
this correct to have the row called adjusted?]
Table 2: Effect of StopAdvisor on biochemically verified smoking cessation
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verification criteria between intervention groups, the 
new analyses showed a similar pattern of results as those 
reported in table 2 (appendix). In the subsample with 
lower socioeconomic status, StopAdvisor showed benefit 
compared with information only; however, results were 
not significant (self-reported 6 month abstinence 
141 [13%] of 1088 vs 114 [11%] of 1054 participants, 
unadjusted RR 1·20, 95% CI 0·95–1·51; p=0·13; adjusted 
RR 1·23, 0·97–1·56; p=0·08; self-reported point-
prevalence 227 [21%] vs 195 [19%] participants, unadjusted 
RR 1·13, 0·95–1·34; p=0·17; adjusted RR 1·18, 0·99–1·40; 
p=0·07 ). That statistical tests in participants with low 
socioeconomic status subsample failed to reach 
significance was probably related to the decreased power 
to detect a percentage difference between the two groups 
because of the increased absolute rates.
StopAdvisor was used more regularly than the control 
website in terms of log-ins, page views, and time spent 
on the website (table 3). This effect was evident in both 
socioeconomic status subsamples, but was slightly larger 
in patients with higher socioeconomic status. In the 
StopAdvisor group, 1216 participants (52%; low 
socioeconomic status 535 [49%] of 1088 participants; 
high socioeconomic status 681 [55%] of 1233 participants) 
chose to use the interactive calendar to set a quit date and 
741 (32%; low socioeconomic status 327 [30%]; high 
socioeconomic status 414 [34%]) opted to report use of a 
stop smoking drug and receive ongoing advice tailored to 
the drug type. In both socioeconomic status subsamples, 
in participants accessing the pre-quit interactive menu, 
the item most often selected at least once during the first 
visit was a section entitled ‘what is the secret to success?’, 
which aimed to boost motivation and self-effectiveness, 
strengthen ex-smoker identity, and offer advice about 
stop-smoking drugs (low socioeconomic status 302 [28%] 
of 1069 participants; high socioeconomic status 436 [36%] 
of 1223 participants). This item remained the most 
popular in participants who revisited the menu before 
their quit date (low socioeconomic status 105 [33%] of 
319 participants; high socioeconomic status 133 [37%] of 
359 participants). During the first post-quit date dialogue 
session, of participants who reported cravings and 
received a self-regulatory control tip, most requested at 
least one additional tip (low socioeconomic status 
108 [53%] of 204 participants; high socioeconomic status 
181 [65%] of 280 participants). Of participants visiting the 
post-quit interactive menu, the items most often selected 
at least once during the first visit by smokers of low 
socioeconomic status (n=260) were the ‘your progress’ 
section, which tracked days since quitting, money saved, 
and health benefits accrued (n=68 [26%]); audio of 
relaxation techniques (n=54 [21%]); and sections 
featuring a gallery of motivational pictures and music to 
improve mood and distract (n=both 52 [20%]), whereas 
smokers with high socioeconomic status (n=378) selected 
sections monitoring ‘your progress’ (140 [37%]), why 
cigarettes are addictive (94 [25%]), and frequently asked 
questions (91 [24%]). During re-visits to this menu, the 
‘your progress’ section remained the most often selected 
at least once in both subsamples (low socioeconomic 
status 142 [67%] of 215; high socioeconomic status 
219 [68%] of 320).
Assessment of outcomes omitted from the main 
analyses on the basis of low response rates (ranging from 
21% to 48% [A: please provide exact numbers with 
percentages]) was consistent with analyses of the primary 
and secondary outcomes (appendix). Self-reported 
abstinence at 2 months and 4 months after enrolment 
was numerically, but not significantly, greater in 
participants allocated to StopAdvisor than in those 
allocated to the control website in the subsample with 
lower socioeconomic status, whereas the rates were 
almost identical in those with higher socioeconomic 
status (data not shown). Self-report of a serious quit 
attempt was similar between groups in both 
socioeconomic status subsamples, and the satisfaction 
ratings were consistently higher for StopAdvisor than 
with the control website (data not shown).
Discussion
Our findings show that overall rates of cessation were 
similar between participants allocated to the interactive 
StopAdvisor website and those in the brief-advice control 
group, but the intervention effect was dependent on 
socioeconomic status—StopAdvisor was an effective aid 
to smoking cessation in smokers of lower, but not higher, 
socioeconomic status. Furthermore, StopAdvisor 
resulted in greater usage than did the static, brief-advice 
website.
Health inequality is a global research priority. A 
strength of this study is that, to our knowledge, it is the 
first to focus on the effect of internet support on smoking 
StopAdvisor 
(n=2321)
Control 
(n=2292)
t test Mean difference 
(95% CI)
p value
Log-ins*
Higher SES 5·0 (6·2) 1·4 (0·7) t(1267) 20·1 3·6 (3·2–3·9) <0·0001
Lower SES 4·1 (5·7) 1·3 (0·6) t(1113) 16·4 2·9 (2·5–3·2) <0·0001
Total time (min)†
Higher SES 26·9 (38·9) 1·3 (3·2) t(1248) 23·1 25·6 (23·5–27·8) <0·0001
Lower SES 22·1 (34·4) 1·1 (2·5) t(1099) 20·1 21·1 (19·0–23·1) <0·0001
Total page views
Higher SES 93·1 (119·8) 6·1 (5·2) t(1237) 25·5 87·0 (80·3–93·7) <0·0001
Lower SES 75·5 (105·0) 5·3 (4·1) t(1090) 22·0 70·2 (64·0–76·5) <0·0001
Data are mean (SD), unless otherwise indicated. All analyses in this table are unadjusted. SES=socioeconomic status. 
*The modal number of log-ins was 1 for both treatments in each SES subsample. The appendix provides log-in data 
presented categorically. †Time on website is an underestimate–time on last page is always unknown in LifeGuide 
interventions. Interaction between a browser and LifeGuide server happens when a page is loaded. After that, there is 
no further communication until another page is loaded from the same server. Time on page is calculated by taking the 
exact time a page was loaded (from the Lifeguide server) and comparing it with the exact time that the previous page 
in the session was loaded. When a user closes their tab, or just types a different website in to the address bar, no 
interaction happens between the browser and the server, so it is not possible to identify the time the final action 
occurred. [A: what are the numbers in parentheses in the t test column?]
Table 3: Usage of StopAdvisor versus the control website
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within different socioeconomic status groups (panel [A: 
we need to cite the panel somewhere in the discussion. 
Ok here? If so I will renumber the references]). The 
finding that StopAdvisor helped smokers in lower but 
not higher socioeconomic status groups suggests that 
concern about online support being more effective for 
smokers in higher socioeconomic groups smokers is 
unwarranted.11 Findings from previous studies have 
shown that smokers of lower socioeconomic status 
engaged less with internet-based support,11 which may 
have arisen from inequalities in online literacy. However, 
the user testing of StopAdvisor was done exclusively in 
smokers with lower socioeconomic status and seems to 
have been successful in producing an effective website 
for that group.13 This outcome could have been at the 
expense of failing to meet the needs of smokers with 
higher socioeconomic status. Future research should 
explore this possibility with a view to tailor the content of 
StopAdvisor to socioeconomic status. In the meantime, 
StopAdvisor could be implemented easily and made 
freely available; smokers with higher socioeconomic 
status would be unlikely to benefit, but no evidence 
shows that use of the website would lead this group to be 
any less successful at quitting.
Although the effect on cessation in smokers with lower 
socioeconomic status was relatively modest (RR 1·4), this 
finding is clinically significant because of the huge health 
gains associated with stopping smoking. An effect of as 
little as 1% on rates of 6-month sustained abstinence 
would result in at least 3 additional years of life for every 
100 40-year-old smokers treated. 24 Additionally, the effect 
size is not dissimilar to other modes of delivery for 
behavioural support (meta-analyses of cessation after at 
least 6 months compared with nothing or minimal 
controls: telephone counselling RR 1·3 [44 studies based 
on 1557 successes from 12 388 vs 1201 of 
12 423 participants]; individual counselling RR 1·4 
[22 studies based on 564 of 4665 vs 433 of 4922 
participants]; mobile-phone-based intervention RR 1·7 
[five studies based on 444 of 4730 vs 240 of 4370 
participants]),5 and internet-based interventions may be 
more cost-effective than other interventions because of 
the potential reach and relatively small ongoing costs.
The absolute rates of cessation were high in our study: 
8% in the intervention group and 6% in the control group 
in smokers of low socioeconomic status, and 12% across 
both [A: ok?] groups in those of high socioeconomic 
status. By comparison, the rate was 6% across treatment 
groups in the only other trial of internet support to have 
reported biochemically verified measures of sustained 
abstinence,29 whereas a frequently cited assessment of 
text-messaging support for cessation reported rates of 
11% in the intervention group and 5% in the control 
group. 20 The relatively high rates in participants allocated 
to the control website in the present study draws attention 
to the pragmatic nature of the trial, which tested the effect 
of StopAdvisor over and above all other available real-
world treatments, including support offered on the site 
through which participants were recruited to the trial. 
The increased rates in smokers with higher socioeconomic 
status compared with those of lower status shows the 
well-established gradient in success rates between the 
groups.8 Although the quit rates were reduced in 
participants allocated to StopAdvisor in smokers of lower 
socioeconomic status smokers compared with those of 
higher status, the salient point is that the gradient seems 
reduced relative to those allocated to the control website 
in smokers of lower socioeconomic status.
The intervention engaged a large proportion (roughly 
60%) of smokers who had never previously used 
behavioural support. This finding should mitigate 
concern about internet support mainly engaging 
smokers who would otherwise have used treatments 
Panel: Research in context
Systematic review
We consulted a recent Cochrane review and did a meta-analysis of the effectiveness of 
interactive internet-based smoking cessation interventions.10,36 The meta-analysis was 
done at the start of the project and included studies obtained from searches of 
computerised databases done in December, 2008: PubMed (1990–2008/12), PsycINFO 
(1990–2008/12), CINHAL Plus (1990–2008), EconLit (1990–2008/11), ISI Web of Science 
(SCI, SSCI, AHCI; 1990–2008) and CENTRAL (Cochrane Registry of Controlled Trials, 
1990–2008).36 We searched Medline with relevant MeSH terms {[(‘Online Systems’ OR 
‘Internet’) AND ‘Smoking Cessation’] AND ‘Randomized Controlled Trial’}. All other 
databases were searched with free text terms: {[(‘Internet’ OR ‘Online’ OR ‘Web’) AND 
‘Smoking cessation’] AND (‘RCT’ OR ‘Randomi$ed controlled trial’ OR ‘Random* trial’)]}. 
We included 11 relevant randomized controlled trials and found a significant treatment 
effect (RR 1·5), but that there was also significant heterogeneity in effect size. The 
Cochrane review was done in April, 2013, and searched the Cochrane Tobacco Addiction 
Group register for records including the terms ’internet’ or ’www*’ or ’web’ or ’net’ or 
’online’.
The specialised register included results from CENTRAL, MEDLINE, EMBASE, and 
PsycINFO. The review identified 28 relevant studies but clinical and statistical 
heterogeneity limited the ability to pool studies. 10 Although there is a huge potential for 
these interventions to have a high effect at low-cost, our conclusion is that existing 
research has produced mixed results and is limited by a scarcity of biochemically verified 
long-term outcomes. 10 Furthermore, internet-based smoking cessation interventions 
might be less effective for smokers with lower socioeconomic status [A:why?].11 The 
present trial was, to our knowledge, the first to focus on the effect of internet support on 
smoking within different socioeconomic status groups.
Interpretation
Our findings show that the interactive internet-based smoking cessation intervention, 
StopAdvisor, is more effective than an information-only website in smokers with lower, 
but not higher, socioeconomic status. User testing of the website was done exclusively in 
smokers with lower socioeconomic status and seems to have been successful in 
producing an effective website for that group.13 Future research should explore whether 
this outcome was at the expense of meeting the needs of smokers with higher 
socioeconomic status. In the meantime, StopAdvisor could be implemented easily and 
made freely available; smokers with higher socioeconomic status would be unlikely to 
benefit, but there is no evidence that their use of the website would lead them to be any 
less successful.
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with an established evidence base, such as face-to-face 
behavioural support. There is a law of attrition in 
electronic health care, which specifies a substantial 
proportion of users drop out before completion of 
treatment.30 The mean usage of StopAdvisor was between 
four and five log-ins, which compares favourably with 
other relevant trials,31 but masks variability in users, 
whereby a substantial proportion of participants will only 
have used StopAdvisor once. Future research should 
examine how prompts and reminders can best engage an 
increased proportion of users to maintain interaction 
with treatment websites.
Our study has limitations. First, we recruited 
participants directly from the internet. As such, this 
study has shown that the intervention is effective for the 
kinds of smokers of lower socioeconomic status who 
have access to the internet. In the future, whether the 
intervention will be able to reduce health inequalities 
resulting from smoking will also be dependent on 
uptake. The issue is not straightforward, because on one 
hand, smokers with lower socioeconomic status smokers 
tend to have less access to the internet than do those with 
higher status,32 but on the other hand, they are just as 
likely to express interest in use of online support,9 and 
the diffusion of internet access has been rapid and will 
only increase.33 Second, the research was done in a high-
income country. Our findings will not necessarily 
generalise to other countries where lower socioeconomic 
status groups might have less online experience and 
skills than do those in the UK. Although cost-effective 
population approaches to cessation, including internet-
based support, are particularly appealing to individuals 
in low-income and middle-income countries, further 
assessment is needed within those contexts before the 
approach can be recommended confidently. Third, we 
were unable to comprehensively assess participants’ use 
of other treatments during the trial. The effective use of 
other treatments—particularly stop-smoking drugs—
might have been a key moderator of effectiveness. 
StopAdvisor is a complex intervention that has been 
developed on the basis of evidence, theory, user and web-
design input, and with the primary intention that the 
website should be maximally effective. The finding that 
the difference in log-ins, time on webpages, and page 
views between the control and intervention websites was 
similar between socioeconomic status subgroups 
suggests that this type of usage did not mediate the 
effectiveness of StopAdvisor for smokers of lower 
socioeconomic status. Future research should identify 
the causal components, possibly in a series of fractionated 
factorial designs that could allow StopAdvisor to be 
refined and optimised.34,35 That the trial has been done 
with detailed and transparent reporting of the 
development and content of the website should aid this 
process. 13 In the meantime, the trial has pragmatically 
shown that StopAdvisor is more effective than the types 
of websites that are typically used by smokers searching 
for online support in the UK—ie, static information-only 
websites. Fourth, socioeconomic status is a complex 
concept and difficult to assess without an interviewer 
being present. Use of the NS-SEC measure benefitted 
from being validated, but use of an occupationally-based 
assessment of socioeconomic status was limited by the 
classification of never workers into the lower 
socioeconomic status group in the dichotomised version. 
This limitation likely accounted for the greater proportion 
of participants with lower socioeconomic status being in 
full-time education than those with higher socioeconomic 
status. However, the NS-SEC measure did seem to 
accurately report the effect of socioeconomic status in 
other respects: compared with smokers with high 
socioeconomic status, those with lower socioeconomic 
status were less likely to have post-16 qualifications or be 
married, and were more likely to be overweight [A:ok?], 
more dependent smokers who started smoking at a 
younger age. Consistent with this limitation, the benefit 
of StopAdvisor over the information-only control website 
seemed to be slightly greater in the post-hoc sensitivity 
analysis, which excluded smokers in full-time education 
from the subsample with lower socioeconomic status. [A: 
edited to avoid repetition. Please provide a couple of 
sentences stating what should happen next/what 
clinicians should do now]
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